CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema
NCT ID: NCT00213681
Last Updated: 2013-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2002-11-30
2005-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema
NCT00390442
Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema
NCT00912158
OUT-OF-HOSPITAL CPAP STUDY
NCT00439075
Continuous Positive Airway Pressure for Acute Pulmonary Edema
NCT00554580
Effects of CPAP on Ventricular Function Modifications
NCT00455611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Boussignac CPAP - bilevel ventilation support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* breathing frequency of \> 30/min, SpO2 \>90%, use of accessory respiratory muscles
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabienne MORITZ, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2001/059/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.